menu
    • menu

    Company profile for CASI Pharmaceuticals

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Our mission is to become an integrated pharmaceutical company with significant market presence in greater China, while establishing strategic partnerships for global development and commercialization.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CASI PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    9620 Medical Center Drive Suite 300 Rockville, MD 20850
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.casipharmaceuticals.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    CASI Pharma Granted Nasdaq Listing Extension
    CASI Pharma Granted Nasdaq Listing Extension

    23 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-23/casi-pharmaceuticals-receives-extension-from-nasdaq-to-meet-listing-requirements

    PHARMIWEB
    23 Dec 2025
    Share Share
    CASI Pharma Announces $20M Convertible Note Financing
    CASI Pharma Announces $20M Convertible Note Financing

    11 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-11/casi-pharmaceuticals-announces-up-to-20-million-convertible-note-financing

    PHARMIWEB
    11 Dec 2025
    Share Share
    CASI Pharma Reveals CID-103 Itp Study Results At ASH Meeting
    CASI Pharma Reveals CID-103 Itp Study Results At ASH Meeting

    08 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-08/casi-pharmaceuticals-announces-results-from-cid-103-immune-thrombocytopenia-study-at-the-67th-americ

    PHARMIWEB
    08 Dec 2025
    Share Share
    CASI Pharmaceuticals Announces Changes In Board Governance
    CASI Pharmaceuticals Announces Changes In Board Governance

    19 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-19/casi-pharmaceuticals-announces-changes-in-board-governance

    PHARMIWEB
    19 Nov 2025
    Share Share
    CASI Pharma Reveals Q3 2025 Business, Financial Results
    CASI Pharma Reveals Q3 2025 Business, Financial Results

    14 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-14/casi-pharmaceuticals-announces-third-quarter-2025-business-and-financial-results

    PHARMIWEB
    14 Nov 2025
    Share Share
    CASI Pharma Appeals NASDAQ Delisting Decision
    CASI Pharma Appeals NASDAQ Delisting Decision

    10 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-10/casi-pharmaceuticals-receives-and-appeals-delisting-determination-from-nasdaq

    PHARMIWEB
    10 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search